New Two-Drug attack on tough brain cancers
NCT ID NCT07468136
Summary
This study is testing a new combination of two drugs, retifanlimab and DFMO, for people with aggressive brain tumors (high-grade gliomas) that have started growing again. The main goals are to find the safest dose of DFMO to use with retifanlimab and to see if the combination changes the immune cells around the tumor. The trial will enroll about 33 adults who are scheduled for surgery to remove their tumor.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT GLIOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.